Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market 2019 Size, Share, Growth | Global Industry Research Report, 2026

SKU ID :FBUIN-14688181 | Published Date: 01-Sep-2019 | No. of pages: 0
Some of the major companies that are present in the global alpha-1 antitrypsin deficiency treatment market are Grifols S.A., CSL Limited, Baxter, Kamada Ltd., Takeda Pharmaceutical Company Limited, Abeona Therapeutics Inc., and other players.
  • PRICE
  • $4850
    $8850
    $6850
    Buy Now

Our Clients